Company & Sponsor Intelligence
University Hospital Muenster
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials8
Recruiting0
Completed3
Countries2
Therapeutic footprint
multiple_sclerosisneuro_oncologyother_neurologyother_psychiatryparkinsonsstroke
Indexed studies
NCT00574262Quality Assessment in Acute Stroke Care
stroke · GermanyUNKNOWN
stroke · GermanyUNKNOWN
NCT00714311Efficacy of Transference-Focused Psychotherapy for Borderline Personality Disorder
other_psychiatry · AustriaNA
other_psychiatry · AustriaNA
NCT00102284Neuromodulation and Language Acquisition (Project Stage Ia)
other_neurology · GermanyPHASE4
other_neurology · GermanyPHASE4
NCT02461082EMST and TMS for Treatment of Dysphagia in Parkinson's Disease
parkinsons · GermanyNA
parkinsons · GermanyNA
NCT00822068Improvement of Language Disturbances After Stroke by Intensive Training and Electrical Brain Stimulation
stroke · GermanyPHASE2, PHASE3
stroke · GermanyPHASE2, PHASE3
NCT05015543Physical Training in Glioblastoma Patients During Cytotoxic Therapy
neuro_oncology · GermanyNA
neuro_oncology · GermanyNA
NCT04082260Signatures of Immune Reprogramming in Anti-CD52 Therapy of MS: Markers for Risk Stratification and Treatment Response
multiple_sclerosis · GermanyUNKNOWN
multiple_sclerosis · GermanyUNKNOWN
NCT02325440Study to Assess Immune Function and MRI Disease Activity in RRMS Patients When Switching From Natalizumab to Gilenya
multiple_sclerosis · GermanyPHASE4
multiple_sclerosis · GermanyPHASE4
Intelligence layer updated: 2026-10-11 23:31:09.606883+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →